alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### In the Matter of the Accounting of The Farmers’ Loan and Trust Company, as Substituted Trustee under the Will of Ellen McLachlan, Deceased. Mary I. McMillan et al., as Administrators of the Estate of Alice E. Moffat, Deceased, Appellants; The Children’s Aid Society et al., Respondents.

*Matter of Farmers' Loan*& *Trust Co.,*138 App. Div. 121, affirmed.

(Argued September 28, 1910;

decided October 18, 1910.)

Appeal from an order of the Appellate Division of the Supreme Court in the first judicial department, entered May 6, 1910, which affirmed a decree of the New York County Surrogate’s Court settling the accounts of the trustee herein and directing distribution of the trust fund.

*Arthur J. McClure*for appellants.

*George N.*Whittlesey, *Stanley W. Dexter*and *Alexander L. Ilalliday*for respondents.

Order affirmed, with costs, on opinion of Miller, J., below.

Concur: Cullen, Ch. J., IIaight, Yann, Werner, Willard Bartlett, Hiscocic and Chase, J,T.
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES – OXLEY ACT OF 2002








Pursuant to 18 U.S.C. § 1350, the
undersigned officer of Atrion Corporation (the “Company”), hereby certifies, to
such officer’s knowledge, that the Company’s Quarterly Report on Form 10-Q for
the quarter ended March 31, 2009 (the “Report”) fully complies with the
requirements of Section 13(a) or 15(d), as applicable, of the Securities
Exchange Act of 1934 and that the information contained in the Report fairly
presents, in all material respects, the financial condition and results of
operations of the Company.












Dated: May 8,
      2009
            /s/
      Emile A. BattatEmile A.
      BattatChief
      Executive Officer







The foregoing certification is made
solely for purpose of  18 U.S.C. § 1350 and not for any other
purpose.
§ 1546.411 Continuing qualifications of screening personnel. ( a ) *Impairment.* No individual may perform a screening function if he or she shows evidence of impairment, such as impairment due to illegal drugs, sleep deprivation, medication, or alcohol.
( b ) *Training not complete.* An individual who has not completed the training required by § 1546.405 may be deployed during the on-the-job portion of training to perform security functions provided that the individual— ( 1 ) Is closely supervised; and
( 2 ) Does not make independent judgments as to whether individuals or property may enter a sterile area or aircraft without further inspection.
( c ) *Failure of operational test.* No foreign air carrier may use an individual to perform a screening function after that individual has failed an operational test related to that function, until that individual has successfully completed the remedial training specified in the foreign air carrier's security program.
( d ) *Annual proficiency review.* Each individual assigned screening duties shall receive an annual evaluation. The foreign air carrier must conduct and document an annual evaluation of each individual who performs screening functions. An individual who performs screening functions may not continue to perform such functions unless the evaluation demonstrates that the individual— ( 1 ) Continues to meet all qualifications and standards required to perform a screening function;
( 2 ) Has a satisfactory record of performance and attention to duty based on the standards and requirements in the foreign air carrier's security program; and
( 3 ) Demonstrates the current knowledge and skills necessary to courteously, vigilantly, and effectively perform screening functions.
#### § 1019.3 Ex parte communications.

Members and employees of the Board must conform to the standards adopted by the Board in 49 CFR 1102.2.
<PAGE>

                                                                    EXHIBIT 23.1

                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

         As independent public accountants, we hereby consent to the
incorporation of our report dated February 14, 2000 included in this Form
10-K, into the Company's previously filed Registration Statements
(Registration Nos. 33-93066 and 333-39371). It should be noted that we have
not audited any financial statements of the Company subsequent to December
31, 1999 or performed any audit procedures subsequent to the date of our
report.

ARTHUR ANDERSEN LLP

Arthur Andersen LLP

Los Angeles, California
March 24, 2000
Exhibit 10.03


 


TONIX PHARMACEUTICALS HOLDING CORP.


509 Madison Avenue, Suite 306


New York, New York 10022


 


October 15, 2013


 


VIA EMAIL


 


Bruce Daugherty


509 Madison Avenue, Suite 306


New York, New York 10022


 


		Re:	Amendment to Employment Agreement



 


Dear Mr. Daugherty:


 


This letter shall serve
as an amendment to the employment agreement dated April 1, 2012 by and between Tonix Pharmaceuticals Holding Corp. and Bruce Daugherty
(the “Agreement”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Agreement.
Section 4(a) of the Agreement is hereby amended and replaced in its entirety with the following:


 


“From October
15, 2013 to the date on which the Company consummates the sale of at least Twenty Million Dollars ($20,000,000) in additional equity
securities (the “Financing”) the Executive’s base salary shall be one hundred ninety thousand dollars
($190,000) per annum.”


 


The foregoing amendment
shall be effective as of October 15, 2013.


 


TONIX PHARMACEUTICALS HOLDING CORP.


 


 


/s/ SETH LEDERMAN


By:    Seth Lederman


Title:    Chief Executive Officer


 


 


 


Accepted to and agreed this


15th day of October, 2013:


 


 


 


 


/s/ BRUCE DAUGHERTY


Bruce Daugherty
###### Editorial Note on Part 106

#### Editorial Note:

Nomenclature changes to part 106 appear at 70 FR 56088, Sept. 23, 2005.

#### § 106.5 Defined terms used in this subpart.

The following defined terms (see part 105, subpart A, of this subchapter) appear in this subpart: File; Person; State.
```

[Journal of the House of Representatives, 1995]
[Wednesday, May 10, 1995 (63), Para 63.6 Committee Membership]
[Page 655]
[From the U.S. Government Publishing Office, www.gpo.gov]

para.63.6  committee membership

  The SPEAKER pro tempore, Mr. WICKER, laid before the House a 
communication, which was read as follows:

                                                      The Speaker,

                                     House of Representatives,

                                     Washington, DC, May 10, 1995.
     Hon. Bud Shuster,
     Chairman, Committee on Transportation and Infrastructure, 
         U.S. House of Representatives, Washington, DC.
       Dear Mr. Chairman: This is to advise you that 
     Representative Nathan Deal's election to the Committee on 
     Transportation and Infrastructure has been automatically 
     vacated pursuant to clause 6(b) of rule X, effective today.
           Sincerely,
                                                    Newt Gingrich.
```
[Federal Register Volume 72, Number 17 (Friday, January 26, 2007)]
[Notices]
[Pages 3850-3851]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-338]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meetings

    In accordance with section 10(d) of the Federal Advisory Committee 
Act as amended (5 U.S.C., Appendix 2), the Agency for Healthcare 
Research and

[[Page 3851]]

Quality (AHRQ) announces meetings of scientific peer review groups. The 
subcommittees listed below are part of the Agency's Health Services 
Research Initial Review Group Committee.
    The subcommittee meetings will be closed to the public in 
accordance with the Federal Advisory Committee Act, section 10(d) of 5 
U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications are to 
be reviewed and discussed at these meetings. These discussions are 
likely to involve information concerning individuals associated with 
the applications, including assessments of their personal 
qualifications to conduct their proposed projects. This information is 
exempt from mandatory disclosure under the above-cited statutes.

    1. Name of Subcommittee: Health Care Research Training.
    Date: February 8-9, 2007 (Open from 9 a.m. to 9:15 a.m. on 
February 8 and closed for remainder of the meeting).
    Place: Agency for Healthcare Research and Quality (AHRQ), John 
Eisenberg Conference Center, 540 Gaither Road, Rockville, Maryland 
20850.

    2. Name of Subcommittee: Health Care Quality and Effectiveness 
Research.
    Date: February 22-23, 2007 (Open from 8 a.m. to 8:15 a.m. on 
February 22 and closed for remainder of the meeting).
    Place: Agency for Healthcare Research and Quality (AHRQ), John 
Eisenberg Conference Center, 540 Gaither Road, Rockville, Maryland 
20850.

    3. Name of Subcommittee: Health Care Technology and Decision 
Sciences.
    Date: February 22, 2007 (Open from 8:30 a.m. to 8:45 a.m. and 
closed for remainder of the meeting).
    Place: Agency for Healthcare Research and Quality (AHRQ), John 
Eisenberg Conference Center, 540 Gaither Road, Rockville, Maryland 
20850.

    4. Name of Subcommittee: Health Systems Research.
    Date: March 1, 2007 (Open from 8 a.m. to 8:15 a.m. and closed 
for remainder of the meeting).
    Place: Agency for Healthcare Research and Quality (AHRQ), John 
Eisenberg Conference Center, 540 Gaither Road, Rockville, Maryland 
20850.
    Contact Person: Anyone wishing to obtain a roster of members, 
agenda or minutes of the nonconfidential portions of the meetings 
should contact Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Suite 2000, Rockville, Maryland 20850, 
Telephone (301) 427-1554.
    Agenda items for these meetings are subject to change as 
priorities dictate.

    Dated: January 18, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07-338 Filed 1-25-07; 8:45 am]
BILLING CODE 4160-90-M
p.1 

OAR Box 1828 

Prepped by Ollie Stewart 

Document Number: 

210) ll-K-(I)-23 

Docket Number: 

A-83-27 

Printed 11/12/2008 11:12:55 AM Sheet 210 of 325 
P.2 

h\r,g 

"-K-CI)-23 

DISCUSSION PAPER ON ANALYTICAL CAPABILITIES TO EVALUATE 

THE INDUSTRIAL BOILER NSPS. 

EEA, Inc. 

February 1, 1979. 

THIS INFORMATION CAN BE FOUND IN DOCKET A-79-02, ITEM 

II-K-(I)-23
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1994
<PERIOD-END>                               JUN-30-1995
<CASH>                                          96,145
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                70,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    126,611
<INVESTMENTS-CARRYING>                          74,701
<INVESTMENTS-MARKET>                            75,575
<LOANS>                                        664,575
<ALLOWANCE>                                     11,218
<TOTAL-ASSETS>                               1,406,818
<DEPOSITS>                                     946,935
<SHORT-TERM>                                    86,453
<LIABILITIES-OTHER>                             21,582
<LONG-TERM>                                    126,650
<COMMON>                                         7,295
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                      93,495
<TOTAL-LIABILITIES-AND-EQUITY>               1,406,818
<INTEREST-LOAN>                                 31,256
<INTEREST-INVEST>                                6,486
<INTEREST-OTHER>                                13,236
<INTEREST-TOTAL>                                50,978
<INTEREST-DEPOSIT>                              11,239
<INTEREST-EXPENSE>                              18,648
<INTEREST-INCOME-NET>                           32,330
<LOAN-LOSSES>                                    1,700
<SECURITIES-GAINS>                                  12
<EXPENSE-OTHER>                                 40,394
<INCOME-PRETAX>                                 12,253
<INCOME-PRE-EXTRAORDINARY>                      12,253
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     7,661
<EPS-PRIMARY>                                     1.03
<EPS-DILUTED>                                     1.03
<YIELD-ACTUAL>                                    6.20
<LOANS-NON>                                      6,137
<LOANS-PAST>                                     1,009
<LOANS-TROUBLED>                                 8,502
<LOANS-PROBLEM>                                  5,622
<ALLOWANCE-OPEN>                                 9,210
<CHARGE-OFFS>                                    1,341
<RECOVERIES>                                     2,599
<ALLOWANCE-CLOSE>                               11,218
<ALLOWANCE-DOMESTIC>                             8,500
<ALLOWANCE-FOREIGN>                                380
<ALLOWANCE-UNALLOCATED>                          2,338
        


</TABLE>
§ 159.010-19 Termination of acceptance or recognition: Procedure. ( a ) If the Coast Guard receives evidence of grounds for termination of acceptance or recognition of an independent laboratory under § 159.010-17, the Commandant will notify the laboratory that termination is under consideration. The laboratory may submit written comments to the Commandant within 21 days of receipt of the notification. The Commandant will take all timely written comments into account before taking final action in the matter, and in no case will the Commandant take final action until at least 30 days after the laboratory has received the notification. Any final action taken by the Commandant is final agency action on the matter.
( b ) If a deficiency could materially affect the validity of an approval issued under an applicable subpart, the Commandant may temporarily suspend the acceptance of the laboratory and may direct the holder of the certificate of approval to cease claiming that the items tested or inspected by the laboratory are Coast Guard approved, pending a final decision in the matter.
[CGD 93-055, 61 FR 13929, Mar. 28, 1996]
69–008

106TH CONGRESS REPORT " ! HOUSE OF REPRESENTATIVES 1st Session 106–159

PROVIDING FOR THE CONSIDERATION OF H.R. 1906, THE AGRICULTURE,

RURAL DEVELOPMENT, FOOD AND DRUG ADMINISTRATION, AND RELATED AGENCIES APPROPRIATIONS BILL, 2000

MAY 24, 1999.—Referred to the House Calendar and ordered to be printed

Mr. DIAZ-BALART, from the Committee on Rules,

submitted the following

REPORT

[To accompany H. Res. 185]

The Committee on Rules, having had under consideration House

Resolution 185, by a nonrecord vote, report the same to the House

with the recommendation that the resolution be adopted.

SUMMARY OF PROVISIONS OF RESOLUTION

The resolution provides for the consideration of H.R. 1906, the

‘‘Agriculture, Rural Development, Food and Drug Administration,

and Related Agencies Appropriations Bill, 2000,’’ under an open

rule. The rule provides one hour of general debate divided equally

between the chairman and ranking minority member of the Committee on Appropriations.

The rule waives clause 4(a) of rule XIII (requiring a 3 day layover of the committee report) and section 306 of the Congressional

Budget Act (prohibiting consideration of legislation within the

Budget Committee’s jurisdiction, unless reported by the Budget

Committee) against consideration of the bill. The rule further

waives clause 2 of rule XXI (prohibiting unauthorized and legislative provisions in an appropriations bill) against provisions in the

bill.

Members who have preprinted their amendments in the Record

prior to their consideration may be given priority in recognition to

offer their amendments if otherwise consistent with House rules.

The Chairman of the Committee of the Whole may postpone votes

during consideration of the bill, and reduce voting time to five minutes on a postponed question if the vote follows a fifteen minute

vote. Finally, the rule provides for one motion to recommit, with or

without instructions.
2

The waiver of clause 4(a) of rule XIII against consideration of the

bill is necessary because the report was not printed until Monday,

May 24, and the bill is scheduled to be considered on the floor on

Tuesday, May 25. Also, the waiver of section 306 of the Congressional Budget Act is necessary because Sec. 733 of the bill, relating

to user fee proposals in budget submissions, is within the Budget

Committee’s jurisdiction, but was not reported by them. Finally,

the waiver of clause 2 of rule XXI against provisions in the bill is

necessary because there are both legislative and unauthorized provisions in H.R. 1906. The unauthorized provisions in the bill are

the Dairy Indemnity Program, the Elderly Feeding Program, and

the Emerson-Leland Hunger Fellowships. Title VII of the committee report lists the legislative changes contained in the bill.

Æ
Release dates | Full version (300 KB PDF)Actions by the Board | Actions 
  under delegated authority
  Applications and reports:Boston
 |
New York
 |
Philadelphia
 |
Cleveland
 |
Richmond
 |
Atlanta
Chicago
 |
St. Louis
 |
Minneapolis
 |
Kansas City
 |
Dallas
 |
San Francisco

# District: 2
Federal Reserve Bank of: New York

## Filings received during the week ending February 26, 2011

|Filer                          | Filing Type    | Filing Proposal                                                                                                                                                  | End of Comment Period                                 
|------------------------------ | -------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------
|BANCA POPOLARE VICENZA SCPAARL | FBSEA          | Banca Popolare di Vicenza S.C.p.A, Vicenza, Italy, to establish a representative office in New York, New York, pursuant to Section 211.24(a)(1) of Regulation K. | Newspaper:Not availableFederal Register:Not applicable
|Newspaper:                     | Not available 
|Federal Register:              | Not applicable

## Availability of CRA Public Evaluations

|Institution / Location | RSSDID | Exam Date | CRAPublic Date | CRARating | Exam Method
|---------------------- | ------ | --------- | -------------- | --------- | -----------
|NONE                  

## CRA Examinations scheduled for     Quarter of

|Institution | Location
|----------- | --------
|NONE       

* Subject to the provisions of the Community Reinvestment Act

Release dates | Full version (300 KB PDF)Actions by the Board | Actions 
  under delegated authority
  Applications and reports:Boston
 |
New York
 |
Philadelphia
 |
Cleveland
 |
Richmond
 |
Atlanta
Chicago
 |
St. Louis
 |
Minneapolis
 |
Kansas City
 |
Dallas
 |
San Francisco

---

Home Banking information and regulation  Accessibility Contact 
  us
#### John I. Lawrence and others, *Trustees, Appellants, v.*Charles Kohlman, Respondent.

Order affirmed, with ten dollars costs and disbursements.
#### Reuben Van Tassel *v.*David Marks.

Order affirmed, with ten dollars costs and disbursements. Opinion by

Brady, J.
Electronically Filed

Intermediate Court of Appeals

CAAP-17-0000507

07-FEB-2019

07:48 AM
#### § 560.8 Submission of decision to the President.

Concurrently with the submission of any decision imposing sanctions to the Federal Register pursuant to § 560.7(d)(1), the Commission shall transmit that decision to the President of the United States who may, within ten days after receiving the decision, disapprove it if the President finds that disapproval is required for reasons of the national defense or the foreign policy of the United States.

[67 FR 39862, June 11, 2002]
Release dates | Full version (300 KB PDF)Actions by the Board | Actions 
  under delegated authority
  Applications and reports:Boston
 |
New York
 |
Philadelphia
 |
Cleveland
 |
Richmond
 |
Atlanta
Chicago
 |
St. Louis
 |
Minneapolis
 |
Kansas City
 |
Dallas
 |
San Francisco

# District: 4
Federal Reserve Bank of: Cleveland

## Filings received during the week ending November 20, 2010

|Filer | Filing Type | Filing Proposal | End of Comment Period
|----- | ----------- | --------------- | ---------------------
|NONE 

## Availability of CRA Public Evaluations

|Institution / Location | RSSDID | Exam Date | CRAPublic Date | CRARating | Exam Method
|---------------------- | ------ | --------- | -------------- | --------- | -----------
|NONE                  

## CRA Examinations scheduled for First Quarter of 2011 (January 1, 2011 - March 31, 2011)

|Institution | Location
|----------- | --------
|NONE       

* Subject to the provisions of the Community Reinvestment Act

Release dates | Full version (300 KB PDF)Actions by the Board | Actions 
  under delegated authority
  Applications and reports:Boston
 |
New York
 |
Philadelphia
 |
Cleveland
 |
Richmond
 |
Atlanta
Chicago
 |
St. Louis
 |
Minneapolis
 |
Kansas City
 |
Dallas
 |
San Francisco

---

Home Banking information and regulation  Accessibility Contact 
  us
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C.
§1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the
Quarterly Report of MGI PHARMA, Inc. (the Company) on Form 10-Q for the period ended June 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Leon O. Moulder, Jr., President and
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.



/s/    LEON O. MOULDER,
JR.Leon O. Moulder, Jr. President and Chief Executive Officer




July 28, 2003



A signed original of this written statement as required
by Section 906, or any other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to MGI PHARMA,
INC. and will be retained by MGI PHARMA, INC. and furnished to the Securities and Exchange Commission or its staff upon request.